Healthcare Business Replay: Synergetics & Uroplasty Shares Jump, Acura’s Patent Problems

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Two medical instruments stocks jumped Thursday from a boost given by Stephens: Synergetics USA, Inc. (NASDAQ:SURG) and Uroplasty, Inc. (NASDAQ:UPI) were both started at Overweight. The former designs microsurgical instruments used primarily for ophthalmology and neurosurgery markets, and the latter is a medical device firm that develops, manufactures and markets products for the treatment of voiding dysfunctions.

Don’t Miss: Analysts Stay Neutral on Tobacco Stocks.

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) has received notification from a generic sponsor of its filing of an Abbreviated New Drug Application for a generic version of Oxecta Tablets, that says it believes that Acura’s patents are invalid, unenforceable or not infringed. Pfizer Inc. (NYSE:PFE) licenses Oxecta, but it’s covered by United States patents that were issued to Acura, who promises that it will take appropriate action to enforce its intellectual property.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business